SUCLA2 and pancreatic adenocarcinoma: As previous studies reported, GLS was expressed highly in PAAD and could be regulated by transcription factor EB (TFEB) [67] and SUCLA2 23, which suggested that there might exist a complex regulation network related to GLS in PAAD.